These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 8326972)
21. Pilocarpine treatment in a mixed cohort of xerostomic patients. Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436 [TBL] [Abstract][Full Text] [Related]
22. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308 [TBL] [Abstract][Full Text] [Related]
23. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Nagler RM; Nagler A Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066 [TBL] [Abstract][Full Text] [Related]
24. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Fox PC; Atkinson JC; Macynski AA; Wolff A; Kung DS; Valdez IH; Jackson W; Delapenha RA; Shiroky J; Baum BJ Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017 [TBL] [Abstract][Full Text] [Related]
25. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study. Schiff E; Mogilner JG; Sella E; Doweck I; Hershko O; Ben-Arye E; Yarom N J Pain Symptom Manage; 2009 Jun; 37(6):1086-1092.e1. PubMed ID: 19186028 [TBL] [Abstract][Full Text] [Related]
26. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229 [TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Haddad P; Karimi M Radiother Oncol; 2002 Jul; 64(1):29-32. PubMed ID: 12208571 [TBL] [Abstract][Full Text] [Related]
28. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775 [TBL] [Abstract][Full Text] [Related]
29. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Wiseman LR; Faulds D Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213 [TBL] [Abstract][Full Text] [Related]
30. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Wasserman TH; Brizel DM; Henke M; Monnier A; Eschwege F; Sauer R; Strnad V Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):985-90. PubMed ID: 16253773 [TBL] [Abstract][Full Text] [Related]
32. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia. Ngeow WC; Chai WL; Rahman RA; Ramli R Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of pilocarpine in postradiation xerostomia. Greenspan D; Daniels TE Cancer; 1987 Mar; 59(6):1123-5. PubMed ID: 3815287 [TBL] [Abstract][Full Text] [Related]
34. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Hawthorne M; Sullivan K Int J Palliat Nurs; 2000 May; 6(5):228-32. PubMed ID: 12419994 [TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. Rhodus NL; Bereuter J J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169 [TBL] [Abstract][Full Text] [Related]
36. Xerostomia: a day and night difference. Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589 [TBL] [Abstract][Full Text] [Related]
37. Radiation-induced xerostomia: how dry is your patient? Bruce SD Clin J Oncol Nurs; 2004 Feb; 8(1):61-7. PubMed ID: 14983765 [TBL] [Abstract][Full Text] [Related]
38. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470 [TBL] [Abstract][Full Text] [Related]
39. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer. Rieger JM; Jha N; Lam Tang JA; Harris J; Seikaly H Head Neck; 2012 Feb; 34(2):168-74. PubMed ID: 21416547 [TBL] [Abstract][Full Text] [Related]
40. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]